The following resources are available to download to provide you with further information about DUPIXENT and support you in treating your patients with atopic dermatitis (AD)
- DUPIXENT Summary of Product Characteristics. September 2021.
AD, atopic dermatitis; DLQI, Dermatology Life Quality Index; EASI, Eczema Area and Severity Index; POEM, Patient Oriented Eczema Measure.
MAT-IE-2101006(v6.0) | Date of preparation: February 2022